The Medicines Company exited the infectious disease business last year when it sold three bacteria-fighting products to Melinta Therapeutics. But Melinta didn’t get all of the company’s bug-fighting drugs, and what’s left has become a new company—Qpex Biopharma.
San Diego-based Qpex... Read more »
Invenra, a Madison, WI-based startup that develops therapeutic antibodies for pharmaceutical companies and other clients, has raised more than $7.1 million from investors, according to a regulatory filing.
Twenty-three investors participated in the equity funding round, according to the... Read more »
[Updated 10/19/18, 5:08 pm. See below.] Rumors of a Boston adtech sale, a top-level departure at IBM’s Watson Health business, more cash to boost A.I. startups, and Boeing backing a space propulsion company dominate the Boston-area’s tech headlines from... Read more »
Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO.
The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced... Read more »
Two new battlegrounds emerged this week in the nation’s ongoing drug pricing debate. The first involved television: The federal government hopes that blaring prices in TV ads will essentially pressure drug makers into lowering them, and the pharma lobby fired back.... Read more »
LogicBio Therapeutics has joined the list of biotechs to go public this year but it had to cut the price of its IPO and sell more shares to pull it off.
The Cambridge, MA, biotech priced its offering of 7 million... Read more »
The race to get driverless cars on the road is a global endeavor, and one nation putting its pedal to the metal is Israel. A host of Israeli companies are working to develop the technologies that help these vehicles function properly,... Read more »
Austin—RealSavvy, a customizable online service that enables real estate brokers and agents to communicate with potential clients, is taking a $2.5 million round of financing that the company will repay in payments based on its monthly revenue.
Timia Capital is... Read more »
Exact Sciences has gone from being a customer of Biomatrica, a San Diego-based vendor of equipment for storing and preserving blood and saliva samples, to now being the company’s owner.
Madison, WI-based Exact (NASDAQ: EXAS), which is developing diagnostic tests... Read more »